Source: Health Canada shortage reports · Updated Jul 29, 2026
Some Sitagliptin products are in shortage in Canada (11 of 24 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Jan 7, 2027.
A diabetes medication used to help control blood sugar in type 2 diabetes.
Products affected
11 / 24
In shortage since
Mar 20, 2024
Est. full return
Jan 7, 2027
Reports on file
47
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
JAMP SITAGLIPTIN
100MG · TABLET · JAMP PHARMA CORPORATION
DIN 02534150 · since Mar 12, 2026, est. end Aug 21, 2026 · Disruption of the manufacture of the drug.
Active shortage
PMS-SITAGLIPTIN
50MG · TABLET · PHARMASCIENCE INC
DIN 02503859 · since Jul 3, 2025, est. end Jan 7, 2027 · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
100MG · TABLET · APOTEX INC
DIN 02508672 · since Aug 12, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
100MG · TABLET · APOTEX INC
DIN 02508672 · since Oct 14, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
50MG · TABLET · APOTEX INC
DIN 02508664 · since Nov 4, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
50MG · TABLET · APOTEX INC
DIN 02508664 · since Nov 18, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
25MG · TABLET · APOTEX INC
DIN 02508656 · since Oct 14, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
25MG · TABLET · APOTEX INC
DIN 02508656 · since Oct 14, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
APO-SITAGLIPTIN MALATE
100MG · TABLET · APOTEX INC
DIN 02508672 · since Oct 14, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-SITAGLIPTIN MALATE
50MG · TABLET · TEVA CANADA LIMITED
DIN 02522713 · since Mar 5, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-SITAGLIPTIN MALATE
25MG · TABLET · TEVA CANADA LIMITED
DIN 02522705 · since Mar 5, 2025, no end estimate · Disruption of the manufacture of the drug.
Active shortage
TEVA-SITAGLIPTIN MALATE
100MG · TABLET · TEVA CANADA LIMITED
DIN 02522721 · since Mar 5, 2025, no end estimate · Disruption of the manufacture of the drug.
Showing 12 of 47 reports. All reports are on file with Health Canada.
What's happening
Sitagliptin is currently affected by 11 active shortage reports filed with Health Canada by JAMP PHARMA CORPORATION, PHARMASCIENCE INC, APOTEX INC, TEVA CANADA LIMITED and 1 others.
The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Sitagliptin is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BH).
Recent changes
Jul 29, 2026
Estimated end date pushed back : Aug 7, 2026 → Aug 21, 2026
Jul 24, 2026
Shortage resolved
Jul 9, 2026
New report filed
Jul 9, 2026
New report filed
Jul 9, 2026
New report filed
Common questions
What is Sitagliptin used for?
A diabetes medication used to help control blood sugar in type 2 diabetes.
When will Sitagliptin be back in stock in Canada?
The latest manufacturer estimate is Jan 7, 2027. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Sitagliptin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.